Perinatal inflammation and childhood adiposity - a gender effect?

J Matern Fetal Neonatal Med. 2020 Apr;33(7):1203-1210. doi: 10.1080/14767058.2018.1517315. Epub 2018 Sep 27.

Abstract

Background: To determine the association of maternal and fetal inflammatory factors with gender-specific infant adiposity, independent of leptin.Methods: Analysis of anthropometry from 265 mother-infant pairs at birth and 280 pairs at 6 months from the randomised control trial of low glycaemic index diet in pregnancy (ROLO) study (Randomised control trial of low glycaemic index diet) and their association with Maternal TNF-alpha, interleukin 6 and leptin as measured in early and late pregnancy and fetal levels in cord blood.Results: No associations were noted in the male cohort. On multiple regression amongst the female neonatal cohort late pregnancy IL-6 was inversely associated with sum of skinfolds (p ≤ .001); at 6 months infant sum of skinfolds were positively associated with early pregnancy IL-6 (p = .046) and central adiposity positively associated with early pregnancy TNF alpha (p = .018) independent of leptin.Conclusion: Although maternal inflammatory cytokines were not associated with neonatal adiposity independent of leptin (as this association is known), both IL-6 and TNF-α were associated with female infant anthropometry at 6 months of age independent of leptin. These results suggest inflammatory cytokines may exert an in-utero influence on later infant adiposity with a tendency to influence female adiposity more than male. Further research is required to ascertain whether these cytokines may be used as reliable early predictors of infant adiposity.

Keywords: IL-6; TNFα; in utero; inflammation; offspring.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adiposity*
  • Adult
  • Female
  • Humans
  • Infant, Newborn / physiology*
  • Interleukin-6 / blood*
  • Pregnancy / blood*
  • Sex Characteristics
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • IL6 protein, human
  • Interleukin-6
  • Tumor Necrosis Factor-alpha